Patents by Inventor Eriko Yoshihara

Eriko Yoshihara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11479757
    Abstract: To reduce the effect of L-proline in the reaction of a sarcosine oxidase. A modified sarcosine oxidase having reduced reactivity to L-proline is provided.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: October 25, 2022
    Assignee: KIKKOMAN CORPORATION
    Inventors: Eriko Yoshihara, Keisuke Furukawa, Kazuhiko Shimoji
  • Publication number: 20190218528
    Abstract: To reduce the effect of L-proline in the reaction of a sarcosine oxidase. A modified sarcosine oxidase having reduced reactivity to L-proline is provided.
    Type: Application
    Filed: September 13, 2017
    Publication date: July 18, 2019
    Applicant: KIKKOMAN CORPORATION
    Inventors: Eriko YOSHIHARA, Keisuke FURUKAWA, Kazuhiko SHIMOJI
  • Patent number: 9238802
    Abstract: A flavin-bound glucose dehydrogenase (FAD-GDH) with high substrate specificity for D-glucose. A gene encoding a mutant FAD-GDH with its N-terminal region, containing an amino acid sequence corresponding to MKITAAIITVATAFASFASA that exists in the N-terminal region, deleted from the amino acid sequence of a wild-type FAD-GDH derived from Mucor is introduced into E. coli to obtain an E. coli transformant. Subsequently, this E. coli transformant is cultured to obtain an FAD-GDH with a specific N-terminal region deleted. The transformant allows the production of a large amount of GDH in a short time as compared with the original microorganism. An FAD-GDH that is less susceptible to the effects of dissolved oxygen and allows accurate measurement of glucose even in the presence of sugar compounds other than glucose in a sample.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: January 19, 2016
    Assignee: KIKKOMAN CORPORATION
    Inventors: Ryoko Tajima, Atsushi Ichiyanagi, Eriko Yoshihara, Kozo Hirokawa
  • Patent number: 9074239
    Abstract: A flavin-binding glucose dehydrogenase (FAD-GDH), which in addition to having high substrate specificity and adequate desirable heat stability, is suitable for efficient production, preferably using E. coli, yeast or molds and the like as host cells. The FAD-GDH has amino acid substitutions at positions equivalent to one or more locations selected from the group consisting of position 213, position 368 and position 526 in the amino acid sequence described in SEQ ID NO: 8. The FAD-GDH is acquired from a culture by inserting a gene encoding the FAD-GDH into host cells such as E. coli. A preferable example of the FAD-GDH is FAD-GDH, in which a signal peptide region present in an N-terminal region has been deleted from the amino acid sequence of Mucor-derived FAD-GDH, and which has the aforementioned amino acid substitutions. The FAD-GDH can be preferably used in clinical diagnosis.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: July 7, 2015
    Assignee: KIKKOMAN CORPORATION
    Inventors: Ryoko Tajima, Kozo Hirokawa, Eriko Yoshihara, Yasuko Tanabe
  • Publication number: 20140287445
    Abstract: A flavin-binding glucose dehydrogenase (FAD-GDH), which in addition to having high substrate specificity and adequate desirable heat stability, is suitable for efficient production, preferably using E. coli, yeast or molds and the like as host cells. The FAD-GDH has amino acid substitutions at positions equivalent to one or more locations selected from the group consisting of position 213, position 368 and position 526 in the amino acid sequence described in SEQ ID NO: 8. The FAD-GDH is acquired from a culture by inserting a gene encoding the FAD-GDH into host cells such as E. coli. A preferable example of the FAD-GDH is FAD-GDH, in which a signal peptide region present in an N-terminal region has been deleted from the amino acid sequence of Mucor-derived FAD-GDH, and which has the aforementioned amino acid substitutions. The FAD-GDH can be preferably used in clinical diagnosis.
    Type: Application
    Filed: June 6, 2012
    Publication date: September 25, 2014
    Inventors: Ryoko Tajima, Kozo Hirokawa, Eriko Yoshihara, Yasuko Tanabe
  • Patent number: 8748144
    Abstract: A Heike firefly luciferase having excellent thermostability and storage stability and a process for its production, wherein the amino acid corresponding to position 287 of Heike firefly luciferase is alanine.
    Type: Grant
    Filed: February 16, 2010
    Date of Patent: June 10, 2014
    Assignee: Kikkoman Corporation
    Inventors: Yukako Kodama, Eriko Yoshihara
  • Publication number: 20130309750
    Abstract: A flavin-bound glucose dehydrogenase (FAD-GDH) with high substrate specificity for D-glucose. A gene encoding a mutant FAD-GDH with its N-terminal region, containing an amino acid sequence corresponding to MKITAAIITVATAFASFASA that exists in the N-terminal region, deleted from the amino acid sequence of a wild-type FAD-GDH derived from Mucor is introduced into E. coli to obtain an E. coli transformant. Subsequently, this E. coli transformant is cultured to obtain an FAD-GDH with a specific N-terminal region deleted. The transformant allows the production of a large amount of GDH in a short time as compared with the original microorganism. An FAD-GDH that is less susceptible to the effects of dissolved oxygen and allows accurate measurement of glucose even in the presence of sugar compounds other than glucose in a sample.
    Type: Application
    Filed: November 30, 2011
    Publication date: November 21, 2013
    Inventors: Ryoko Tajima, Atsushi Ichiyanagi, Eriko Yoshihara, Kozo Hirokawa
  • Publication number: 20120295325
    Abstract: A firefly luciferase having the amino acid sequence of firefly luciferase, wherein the amino acid corresponding to position 287 of Heike firefly luciferase is replaced with alanine, or wherein the amino acid corresponding to position 392 is replaced with isoleucine. The firefly luciferase has improved thermostability and storage stability. A firefly luciferase gene coding for the firefly luciferase. By utilizing this gene, it is possible to efficiently produce firefly luciferase with increased stability. It is also possible to obtain firefly luciferase with further increased stability by combination with a mutation in which the amino acid at position 326 is replaced with serine, and/or a mutation in which the amino acid at position 467 is replaced with isoleucine.
    Type: Application
    Filed: February 16, 2010
    Publication date: November 22, 2012
    Applicant: KIKKOMAN CORPORATION
    Inventors: Yukako Kodama, Eriko Yoshihara